1. Home
  2. KXIN vs OGEN Comparison

KXIN vs OGEN Comparison

Compare KXIN & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KXIN
  • OGEN
  • Stock Information
  • Founded
  • KXIN 2015
  • OGEN 1996
  • Country
  • KXIN China
  • OGEN United States
  • Employees
  • KXIN N/A
  • OGEN N/A
  • Industry
  • KXIN Retail-Auto Dealers and Gas Stations
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • KXIN Consumer Discretionary
  • OGEN Health Care
  • Exchange
  • KXIN Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • KXIN 7.5M
  • OGEN 9.8M
  • IPO Year
  • KXIN N/A
  • OGEN N/A
  • Fundamental
  • Price
  • KXIN $0.12
  • OGEN $1.14
  • Analyst Decision
  • KXIN
  • OGEN
  • Analyst Count
  • KXIN 0
  • OGEN 0
  • Target Price
  • KXIN N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • KXIN 1.8M
  • OGEN 131.0K
  • Earning Date
  • KXIN 11-26-2019
  • OGEN 08-12-2024
  • Dividend Yield
  • KXIN N/A
  • OGEN N/A
  • EPS Growth
  • KXIN N/A
  • OGEN N/A
  • EPS
  • KXIN N/A
  • OGEN N/A
  • Revenue
  • KXIN $31,535,000.00
  • OGEN $20,629.00
  • Revenue This Year
  • KXIN N/A
  • OGEN N/A
  • Revenue Next Year
  • KXIN N/A
  • OGEN N/A
  • P/E Ratio
  • KXIN N/A
  • OGEN N/A
  • Revenue Growth
  • KXIN N/A
  • OGEN N/A
  • 52 Week Low
  • KXIN $0.11
  • OGEN $0.97
  • 52 Week High
  • KXIN $5.52
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • KXIN 40.55
  • OGEN 40.97
  • Support Level
  • KXIN $0.12
  • OGEN $1.00
  • Resistance Level
  • KXIN $0.16
  • OGEN $1.19
  • Average True Range (ATR)
  • KXIN 0.01
  • OGEN 0.07
  • MACD
  • KXIN -0.00
  • OGEN 0.03
  • Stochastic Oscillator
  • KXIN 11.63
  • OGEN 61.11

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: